Jeani Delagardelle is a Managing Director and leads
our medical device practice, with almost 30 years of experience in
that industry. Jeani joined Sprout in August 2000 and became General
Partner in July 2001. She was one of the founders of New Leaf upon
its spin-out from Sprout in 2005.
Previously, she was a General Partner at Weiss, Peck & Greer Venture
Partners where she focused on healthcare/technology investments.
Before joining Weiss, Peck & Greer Venture Partners, Jeani spent 15
years in senior marketing, sales, business development and general
manager positions in the healthcare industry. Specifically, she was
Vice President of Global Marketing for Target Therapeutics (acquired
by Boston Scientific for $1.1B) and spent nine years with the Medi-tech
division of Boston Scientific in several senior management roles. In
addition, Jeani served as Director of Business Operations for Roche
Laboratories and Director of Global Marketing for Cell Pro, Inc.
Jeani attended University of California at Irvine (M.B.A.) and
Occidental College (A.B.).
"Jeani Delagardelle, the Board Member from
the New Leaf team recognized the opportunity and its potential, and
acted as a true partner from the very beginning in Visiogen even
before there was a prototype. Jeani helped Visiogen in so many ways
including operations, corporate strategy and with multiple financing
rounds at various stages of the company’s development."
former Chairman and CEO, Visogen, Inc.
Epicor Medical (Acquired by St. Jude Medical)
Interlace (Acquired by Hologic)
Percusurge (Acquired by Medtronic)
ProDuct Health (Acquired by Cyctc, now Hologic)
Visiogen (Acquired by Abbott Medical)
World Heart Corporation (Acquired by HeartWare International)